Menu

Infographic: Triggering Titin

This third filament involved in muscle function is often ignored in medical textbooks. Here's how it works.

Sep 1, 2018
Julio M. Fernández

MUSCULAR DOGMA

The standard textbook model of muscle contraction includes only two main players, the filaments actin and myosin, which slide past each other, causing the sarcomere—the basic unit of muscle tissue—to shorten. Driven by ATP-powered myosin motors, sarcomere contraction causes whole muscles to shorten. In the past 40 years, researchers have explored the role of another filament: titin. Its emerging role in muscle function, unwinding during muscle relaxation and folding during contraction, suggests that the ATP-driven motors also act as latches allowing titin to fold, providing a powerful boost to muscle contraction.

© IKUMI KAYAMA/STUDIO KAYAMA

Relaxed

When sarcomeres are relaxed titin, anchored to teh Z line and the ends of myosin filaments, unwinds.
© IKUMI KAYAMA/STUDIO KAYAMA

Contracted

When sarcomeres contract, titin folds again, adding force to the contraction.
© ikumi kayama/studio kayama


Read the full story.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.

Thermo Fisher Scientific: Freezers for Biological Samples

Thermo Fisher Scientific: Freezers for Biological Samples

Fluctuations in temperature can reduce the efficacy, decompose, or shorten the shelf life of biologics. Therefore, it is important to store biologics at the right temperature using standardized protocols.